High expression of MRPL52 can be used as a prognostic marker of hepatocellular carcinoma and is related to immune infiltration
Nan Huang(Sun Yat-sen University), Zheng LIU(Xiangyang Central Hospital), Qichang Xing(Hubei University of Chinese Medicine), Jia Chen(Xiangyang Central Hospital), Xiang Liu(Xiangyang Central Hospital), Wei Li(Guangzhou University of Chinese Medicine), Xiaolan Guo(North Sichuan Medical University)
Cited by 0
Related Papers
<p>The Role Of PD-1/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy</p>
|OncoTargets and Therapy|2019|236
m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma
|Molecular Cancer|2019|211
Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2
|BMC Cancer|2018|190
The N6‐methyladenosine modification enhances ferroptosis resistance through inhibiting <i>SLC7A11</i> mRNA deadenylation in hepatoblastoma
|Clinical and Translational Medicine|2022|150